Document ID: chunk:federal_register_of_legislation:F2019L01493:clause:1_11
Version: federal_register_of_legislation:F2019L01493
Segment Type: clause
Provision Reference: sch 1 cl 11
Character Range: 8268–9661

11                                       actions taken during the review                 a summary of any relevant actions taken by the relevant sponsor or the Therapeutic Goods Administration during the compliance review of the relevant medicine, for example:
                                                                                            (a) an update to the listing of the relevant medicine on the Register by the relevant sponsor;
                                                                                            (b) an update to the label of the relevant medicine by the relevant sponsor;
                                                                                            (c) a request by the relevant sponsor for the cancellation of the listing of the relevant medicine from the Register following notification of issues;
                                                                                            (d) a request by the relevant sponsor for the cancellation of the listing of the relevant medicine from the Register following a request for information under section 31 of the Act;
                                                                                            (e) the cancellation of the listing of the relevant medicine from the Register by the Secretary, where the cancellation was not at the request of the relevant sponsor